For patients receiving genetic testing due to a family history of a genetic cardiovascular disease, detection of pathogenic variants was predictably higher, though the difference did not reach statistical significance (47% in 2019 and 40% in 2020, p = .31).
← all excerpts
The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic.
1
0.3100
0.3100